期刊文献+

MTX对关节病型银屑病患者血清TNF-α影响的研究 被引量:2

The influence of MTX on serum TNF-α in the patients with psoriasis a rthropathica
下载PDF
导出
摘要 目的:研究肿瘤坏死因子α(TNF-α)在关节病型银屑病发病中的作用及MTX对其调节作用,探讨MTX治疗关节病型银屑病的机制。方法:应用双抗体夹心酶联免疫吸附法(ELISA),检测15例关节病型银屑病患者经MTX治疗前后外周血清中TNF-α的水平。结果:MTX治疗前血清中TNF-α的水平显著高于治疗后及正常人对照组(P<0.001)。结论:TNF-α在关节病型银屑病致病中可能起重要作用。MTX治疗关节病型银屑病的机制可能是通过抑制TNF-α的分泌而达到治疗作用。 Objective: To investigate the influence of MTX on TNF - α in the patients with psoriasis arthropathica and to explore the treatment mechanism. Methods: Serum levels of TNF - α were measured by double antibedy sandwich enzyme- linked immunosorbent assay (ELISA) in 15 patients with psoriasis arthropathica before and after treatment with MTX. Results: The serum level of TNF- α was significantly higher before treatment than that after treatment with MTX and than that in nonnal controls ( P 〈 0. 001 ). Conclusion: TNF - α may play an important role in the pathogenesis of psoriasis arthropathica. Inhibition of the secretion of TNF - α may be related to the treatment of psoriasis arthropathica with MTX.
出处 《中国麻风皮肤病杂志》 2007年第3期206-208,共3页 China Journal of Leprosy and Skin Diseases
基金 广东省卫生厅医学科研立项课题资助(A2004-581)
关键词 甲氨蝶呤 关节病型银屑病 肿瘤坏死因子Α methotrexate psoriasis arthropathica tumor necrosis factor-α
  • 相关文献

参考文献9

  • 1Ruzicka T.Psoriatic arthritis:new types,new treatment.Arch Dermatol 1996; 132:215-219.
  • 2李世泰 解毓章 蒋明.银屑病性关节炎临床和放射学分析[J].中华皮肤科杂志,1987,20(3):151-151.
  • 3Nickloff BJ,Karabin GD,Barker JNW,et al.Cellular localization of interleukin-8 and its inducer,tumor necrosis factor-alpha in psoriasis.Am J Pathol 1991;138:129.
  • 4Mussi A,Bonifati C,Carducci M,et al.Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque type psoriasis.J Boil Regul Homeost Agents 1997;11:115-118.
  • 5Chodorawska G.Plasma concentrations IFN-ganna and TNF-alpha in patients before and after local treatment with dithranol ointment.J Eur Acad Dermatol Venereal 1998;10:147-151.
  • 6Partsch G,Steiner G,Leeb BF,et al.Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriafis arthritis synovial fluid.J Rheumatol 1997;24:518-523.
  • 7冯峥,张郁,李恒进,黎燕.寻常性银屑病患者血清α肿瘤坏死因子水平及生物学活性检测与相关性研究[J].临床皮肤科杂志,2005,34(6):354-355. 被引量:16
  • 8Oh CJ,Das KM,Gottlieb AB.Treatment with anti-tumor necrosis factor-alpha (TNF-alpha) monoclonal activity of dramatically decrease the clinical activity of psoriasis lesions.J Am Acad Dematol 2000;42:829-830.
  • 9Weinstein GD,Frost P.Methotrexate for psoriasis,A new therapeutic schedule.Arch Dermatol 1971;103:33-38.

二级参考文献7

  • 1Mease PJ. Tumour necrosis factor (TNI) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors[J]. Ann Rheum Dis,2002.61(4):298-304.
  • 2Bonifati C, Carducci M, Cordiali Fei P, et al. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease severity [J]. Clin Exp Dermatol,1994,19(5):383-387.
  • 3Ettehadi P, Greaves MW, Wallach D,et al.Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions[J]. Clin Exp Immunol,1994,96(1):146-151.
  • 4Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid[J].Dermatologica,1978,157(4):238-244.
  • 5Goerdt S, Zwadlo G, Schlegel R, et al. Characterization and expression kinetics of an endothelial cell activation antigen present in vivo only in acute inflammatory tissues [J].Exp Cell Biol,1987,55(3):117-126.
  • 6Mussi A, Bonifati C, Carducci M, et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis [J].J Biol Regul Homeost Agents,1997, 11(3):115-118.
  • 7Ritchlin C, Haas-Smith SA, Hicks D, et al. Patterns of cytokine production in psoriatic synovium[J].J Rheumatol,1998, 25(8):1544-1552.

共引文献22

同被引文献37

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部